Artemis Therapeutics Inc. (ATMS)
Artemis Therapeutics Inc. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $0.50, down 73.65% on the session, giving a market capitalisation of $55.8M. On trailing twelve-month figures it carries a trailing P/E of -49.80, a net margin of -434.4%. Its beta of 0.00 implies it has historically moved less than the broad market.
Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Artemis Therapeutics Inc. is most often compared with the following Financial Services names: